Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 11
Submit an article Journal homepage
100
Views
25
CrossRef citations to date
0
Altmetric
Original

CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia

Amjad Hayat Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
David O'Brien Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Paul O'Rourke Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Siobhan McGuckin Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Tony Fitzgerald Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Eibhlin Conneally Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Paul V. Browne Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Shaun R. Mccann Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
,
Mark P. Lawler Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, Ireland
&
Dr Elisabeth Vandenberghe Department of Haematology and Durkan Laboratories, Institute of Molecular Medicine, Trinity College and St James Hospital, Dublin, IrelandCorrespondence[email protected]
 show all
Pages 2371-2379 | Received 20 Apr 2006, Accepted 26 Jul 2006, Published online: 01 Jul 2009

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Niamh Appleby, David O’Brien, Fiona M. Quinn, Liam Smyth, Johanna Kelly, Imelda Parker, Kathleen Scott, Mary R. Cahill, Gerard Crotty, Helen Enright, Brian Hennessy, Andrew Hodgson, Maeve Leahy, Hilary O’Leary, Michael O’Dwyer, Amjad Hayat & Elisabeth A. Vandenberghe. (2018) Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL. Leukemia & Lymphoma 59:6, pages 1338-1347.
Read now
Juan Guo, Jiying Su, Qi He, Xiao Li, Youshan Zhao, Shucheng Gu, Chengming Fei & Chunkang Chang. (2016) The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma. Hematology 21:3, pages 152-161.
Read now
Alison Morilla, David Gonzalez de Castro, Ilaria Del Giudice, Nnenna Osuji, Monica Else, Ricardo Morilla, Vasantha Brito Babapulle, Hannah Rudenko, Estella Matutes, Claire Dearden, Daniel Catovsky & Gareth J Morgan. (2008) Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL. Leukemia & Lymphoma 49:11, pages 2108-2115.
Read now
Leeona Galligan, Mark A. Catherwood, Christine Matthews, T. C. M ‘Curly' Morris & H Dennis Alexander. (2008) Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia. Leukemia & Lymphoma 49:4, pages 763-768.
Read now
Y. M. Yang & J. W. Chang. (2008) Current Status and Issues in Cancer Stem Cell Study. Cancer Investigation 26:7, pages 741-755.
Read now
Terry Hamblin. (2006) Prognostic factors in chronic lymphocytic leukemia. Leukemia & Lymphoma 47:11, pages 2261-2262.
Read now

Articles from other publishers (19)

Heba A. Ahmed, Asmaa Nafady, Eman H. Ahmed, Emad Eldin Nabil Hassan, Walaa Gamal Mohamed Soliman, Mahmoud I. Elbadry & Ahmed Ahmed Allam. (2023) CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia. Annals of Hematology.
Crossref
Kamil Wdowiak, Enrique Gallego‑Colon, Tomasz Francuz, Paulina Czajka‑Francuz, Natalia Ruiz‑Agamez, Marcin Kubeczko, Iga Grochoła, Maciej Wybraniec, Jerzy Chudek & Jerzy Wojnar. (2018) Increased serum levels of Galectin‑9 in patients with chronic lymphocytic leukemia. Oncology Letters.
Crossref
Alain Mina, Jose Sandoval Sus, Elsa Sleiman, Javier Pinilla-Ibarz, Farrukh T. Awan & Mohamed A. Kharfan-Dabaja. (2018) Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?. Blood Reviews 32:2, pages 159-166.
Crossref
Jin Roh, Su-Jin Shin, A-Neum Lee, Dok Hyun Yoon, Cheolwon Suh, Chan-Jeoung Park, Jooryung Huh & Chan-Sik Park. (2017) RGS1 expression is associated with poor prognosis in multiple myeloma. Journal of Clinical Pathology 70:3, pages 202-207.
Crossref
Carlos I. Amaya-Chanaga & Laura Z. Rassenti. (2016) Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers. Best Practice & Research Clinical Haematology 29:1, pages 79-89.
Crossref
Huayuan Zhu, Wei Wu, Yuan Fu, Wenyi Shen, Kourong Miao, Min Hong, Wei Xu, Ken H. Young, Peng Liu & Jianyong Li. (2013) Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia. Annals of Hematology 93:3, pages 425-435.
Crossref
John C. Byrd & Joseph M. Flynn. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1958 1978.e7 .
Paula Cramer & Michael Hallek. (2010) Prognostic factors in chronic lymphocytic leukemia—what do we need to know?. Nature Reviews Clinical Oncology 8:1, pages 38-47.
Crossref
B. D. Hock, J. L. McKenzie, L. McArthur, S. Tansley, K. G. Taylor & L. J. Fernyhough. (2010) CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data. Internal Medicine Journal 40:12, pages 842-849.
Crossref
Nagwa M. Hassanein, Kathryn R. Perkinson, Felisa Alcancia, Barbara K. Goodman, J. Brice Weinberg & Anand S. Lagoo. (2010) A Single Tube, Four-Color Flow Cytometry Assay for Evaluation of ZAP-70 and CD38 Expression in Chronic Lymphocytic Leukemia. American Journal of Clinical Pathology 133:5, pages 708-717.
Crossref
A. Hayat, S. McGuckin, E. Conneally, P. V. Brown, S. R. McCann, M. Lawler, F. Quinn, E. Delaney, P. O’Rourke, S. Liptrot, D. O’Brien & E. Vandenberghe. (2009) Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia. Irish Journal of Medical Science 178:4, pages 441-446.
Crossref
Anthony M. McElligott, Elaina N. Maginn, Lisa M. Greene, Siobhan McGuckin, Amjad Hayat, Paul V. Browne, Stefania Butini, Giuseppe Campiani, Mark A. Catherwood, Elisabeth Vandenberghe, D. Clive Williams, Daniela M. Zisterer & Mark Lawler. (2009) The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia. Cancer Research 69:21, pages 8366-8375.
Crossref
Chris PepperSaman HewamanaPaul BrennanChris Fegan. (2009) NF-κB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia. Future Oncology 5:7, pages 1027-1037.
Crossref
Femke Van Bockstaele, Bruno Verhasselt & Jan Philippé. (2009) Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews 23:1, pages 25-47.
Crossref
Carlos E. Pedreira, Elaine S. Costa, Susana Barrena, Quentin Lecrevisse, Julia Almeida, Jacques J. M. van Dongen & Alberto Orfao. (2008) Generation of flow cytometry data files with a potentially infinite number of dimensions. Cytometry Part A 73A:9, pages 834-846.
Crossref
Fabio Malavasi, Silvia Deaglio, Ada Funaro, Enza Ferrero, Alberto L. Horenstein, Erika Ortolan, Tiziana Vaisitti & Semra Aydin. (2008) Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology. Physiological Reviews 88:3, pages 841-886.
Crossref
Gema Mateo, M. Angeles Montalbán, Maria-Belén Vidriales, Juan J. Lahuerta, Maria V. Mateos, Norma Gutiérrez, Laura Rosiñol, Laura Montejano, Joan Bladé, Rafael Martínez, Javier de la Rubia, Joaquín Diaz-Mediavilla, Anna Sureda, José M. Ribera, José M. Ojanguren, Felipe de Arriba, Luis Palomera, Maria J. Terol, Alberto Orfao & Jesús F. San Miguel. (2008) Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy. Journal of Clinical Oncology 26:16, pages 2737-2744.
Crossref
M A Kaderi, M Norberg, F Murray, M Merup, C Sundström, G Roos, A Åleskog, K Karlsson, T Axelsson, G Tobin & R Rosenquist. (2007) The BCL-2 promoter (−938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia. Leukemia 22:2, pages 339-343.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:3, pages 148-155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.